Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis
Author Information
Author(s): Petrella Stéphanie, Gelus-Ziental Nathalie, Maudry Arnaud, Laurans Caroline, Boudjelloul Rachid, Sougakoff Wladimir
Primary Institution: UPMC Université Paris 6, ER 5 (EA1541) Bactériologie-Hygiène, Faculté de Médecine Pitié-Salpêtrière, Paris, France
Hypothesis
How do mutations in the pncA gene affect pyrazinamide resistance in Mycobacterium tuberculosis?
Conclusion
The study reveals significant structural differences in the pyrazinamidase of Mycobacterium tuberculosis that contribute to its resistance to pyrazinamide.
Supporting Evidence
- The crystal structure shows significant differences in the substrate binding cavity compared to other pyrazinamidases.
- Mutations in the pncA gene lead to diverse resistance mechanisms in clinical isolates.
- Thermal stability and protein folding are crucial for the pyrazinamidase activity.
Takeaway
This study looks at a protein that helps tuberculosis bacteria resist a key drug. By understanding its structure, scientists can learn why some bacteria don't get killed by the medicine.
Methodology
The crystal structure of the pyrazinamidase was determined using X-ray crystallography at a resolution of 2.2 Å.
Limitations
The study primarily focuses on structural analysis and does not address all potential factors influencing drug resistance.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website